Early results of a real-world series with two transapical transcatheter mitral valve replacement devices

Figures

• 

  Fig. 1. Echocardiographic changes before and after TMVR. a Stroke volume index (SVI) (mL/m2). b Left ventricular end-diastolic volume (LVEDV). LVEDV left ventricular end-diastolic volume, SVI stroke volume index, TMVR transcatheter mitral valve replacement

• 

  Fig. 2. Mitral regurgitation before TMVR and at follow-up. TMVR transcatheter mitral valve replacement

• 

  Fig. 3. NYHA class distribution before TMVR and at follow-up. NYHA New York heart association, TMVR transcatheter mitral valve replacement

• 

  Fig. 4. Tendyne™ (Abbott Vascular) and prior AVR. (3Mensio Structural Heart, V10.0, Pie Medical Imaging, Maastricht, Netherlands). a 3D reconstruction of three-chamber view. b 3D en face view (“surgeon’s view”) of the device. c 2D three-chamber view. d 2D en face view of the device

• 

  Fig. 5. Tiara™ (Neovasc Inc.). (3Mensio Structural Heart, V10.0, Pie Medical Imaging, Maastricht, Netherlands). a 3D reconstruction of three-chamber view. b 3D en face view (“surgeon’s view”) of the device. c 2D three-chamber view. d 2D en face view of the device